Jira · Handbook of clinical neurology 2013 · narrative review · n=?

Cholesterol metabolism deficiency.

Cited 31 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review without systematic methodology or primary human data.

PubMed 23622407 · doi:10.1016/B978-0-444-59565-2.00054-X · record verified 2026-08-29

What was done

This narrative review summarizes genetic defects in the enzymatic pathways of cholesterol biosynthesis, classifying eight distinct inherited disorders into pre-squalene and post-squalene segments of the pathway.

What was found

The abstract reports no quantitative data. It identifies eight distinct inherited disorders linked to cholesterol biosynthesis deficiencies, including two pre-squalene defects (classical mevalonic aciduria and hyperimmunoglobulinemia D syndrome) and six post-squalene defects (Smith-Lemli-Opitz syndrome, Conradi-Hünermann-Happle syndrome, CHILD syndrome, Greenberg skeletal dysplasia, lathosterolosis, and desmosterolosis). These disorders are characterized by elevated pathway-specific sterol intermediates and causal gene mutations, resulting in overlapping clinical phenotypes that include developmental delay, psychomotor retardation, structural brain malformations, microcephaly, cataracts, multiple congenital anomalies, and behavioral disorders.

Why it matters

It provides a structured overview of the molecular and clinical spectrum of inborn errors of cholesterol biosynthesis, highlighting the essential role of sterol intermediates in embryonic development and neurological function.

Limits

As a narrative review, the abstract presents no primary empirical data, sample sizes, systematic search methodology, or quantitative risk estimates.

Cited by